Academic Reading — Test 93

Reading passage

Across much of West Africa, a curious genetic pattern has long puzzled and fascinated researchers. A condition that can cause serious illness, and in its severe form shortens life dramatically, remains surprisingly common in the very regions where one might expect natural selection to have eliminated it. The explanation lies in an unexpected partnership between human genetics and one of the continent's oldest enemies: malaria. The condition is sickle cell trait, and its persistence offers one of the clearest illustrations in all of biology of how a seemingly harmful inheritance can confer a hidden advantage. To understand the phenomenon, it is necessary to distinguish between two related but very different states. Human beings carry two copies of the gene responsible for producing haemoglobin, the protein in red blood cells that transports oxygen around the body. A person who inherits one altered copy and one normal copy is said to have sickle cell trait. Such an individual is generally healthy and usually shows no obvious symptoms throughout ordinary life. By contrast, a person who inherits two altered copies develops sickle cell disease, a painful and life-limiting illness in which red blood cells distort into a rigid, crescent shape, obstructing blood vessels and starving tissues of oxygen. The trait, then, is the milder carrier state; the disease is the severe outcome of a double inheritance. The link to malaria emerges from the behaviour of the malaria parasite inside the human body. After being transmitted through the bite of an infected mosquito, the parasite invades red blood cells and multiplies within them. In a person with sickle cell trait, infected cells are more likely to deform and be destroyed, or to be cleared rapidly by the spleen, before the parasite can complete its development. The result is that carriers who contract malaria tend to suffer milder infections and are far less likely to die from the most dangerous form of the disease. This protection is partial rather than absolute: carriers can still be infected, and they can still fall ill, but their statistical chances of surviving a serious bout are considerably improved. Crucially, this advantage applies to those with the trait, not to those with the full disease, whose health is gravely compromised regardless of any malaria exposure. This sets up what biologists call a balancing act. In regions where malaria has historically been widespread, carrying a single altered gene is advantageous, because it offers protection against a major cause of childhood death. Yet inheriting two altered genes is severely disadvantageous, because it produces the disease. Natural selection therefore pulls in two directions at once. The altered gene is neither driven to extinction, because carriers benefit, nor allowed to spread without limit, because too many double inheritances would be fatal. The frequency of the gene settles at an intermediate level determined by the intensity of malaria in the local environment. This mechanism, in which heterozygous individuals are fitter than either homozygous type, is known to geneticists as balanced polymorphism, and the West African case is its most celebrated example. The geographical evidence reinforces the connection in a striking manner. When researchers map the frequency of the altered gene across Africa, the areas of highest frequency correspond closely to the regions where malaria transmission has been most intense and most sustained over many generations. In some West African communities, a substantial proportion of the population carries the trait. Conversely, in places where malaria has been historically rare or absent, the gene is uncommon. This correspondence between the distribution of a parasite and the distribution of a human gene is regarded as compelling evidence that malaria has acted as the selective pressure shaping the pattern. It is worth noting, however, that the gene is not confined to Africa; similar though independent patterns appear in parts of the Mediterranean, the Middle East and India, wherever malaria has long been a burden. The practical consequences of this genetic legacy remain significant today. Although modern medicine and mosquito-control programmes have reduced malaria in many areas, the altered gene persists in populations, and sickle cell disease therefore continues to affect large numbers of children born across the region. Public health planners must contend with a paradox: the same inheritance that once helped ancestors survive a deadly parasite now imposes a heavy burden of chronic illness. Screening programmes, genetic counselling and improved treatment can ease this burden, but they cannot quickly alter the underlying genetics, which were shaped over countless generations of exposure to malaria. The story of sickle cell trait thus stands as a powerful reminder that the human body is, in part, a record of the diseases its ancestors endured.